We want to shift the paradigm in drug delivery systems.
Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific delivery—targeting only the cells that need therapy and working with the body to bypass immune reactions.
Not only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process.
By advancing drug efficacy, lowering costs, reducing side effects, and shortening time to market, we aim to unlock the potential of new therapies and help make the world’s most advanced medicines more accessible to everyone.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 3900 Paseo Del Sol, Santa Fe,new Mexico 87507,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mercurybio.com
- Keywords
- Drug delivery, Molecular biophysics, Molecular biology, Microbial genetics, Biochemistry, Genetic & Bioinformatics, Computational & Statistical Science, Theoretical Biology.
- HQ
- Santa Fe, New Mexico
Mercury Bio Questions
Mercury Bio's website is http://www.mercurybio.com
Mercury Bio's LinkedIn profile is https://www.linkedin.com/company/mercury-bio
Mercury Bio has
12 employees.
View email and phone details for 12
employees at Mercury Bio.
Mercury Bio's industry is
Biotechnology Research
Mercury Bio's top competitors are
Tevogen Bio,
Integral Molecular,
Kayothera,
Optimeos Life Sciences,
Linusbio,
Nob Hill Therapeutics,
Nereid Therapeutics,
Sandia Biotech, Inc.,
Evrys Bio,
Enceladus Bio.
Mercury Bio's categories are Biotechnology Research
Mercury Bio's founding year is 2020
